742 related articles for article (PubMed ID: 27452466)
81. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells.
Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490
[TBL] [Abstract][Full Text] [Related]
82. The Epithelial Sodium Channel (αENaC) Is a Downstream Therapeutic Target of ASCL1 in Pulmonary Neuroendocrine Tumors.
He M; Liu S; Gallolu Kankanamalage S; Borromeo MD; Girard L; Gazdar AF; Minna JD; Johnson JE; Cobb MH
Transl Oncol; 2018 Apr; 11(2):292-299. PubMed ID: 29413762
[TBL] [Abstract][Full Text] [Related]
83. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
Gay CM; Stewart CA; Park EM; Diao L; Groves SM; Heeke S; Nabet BY; Fujimoto J; Solis LM; Lu W; Xi Y; Cardnell RJ; Wang Q; Fabbri G; Cargill KR; Vokes NI; Ramkumar K; Zhang B; Della Corte CM; Robson P; Swisher SG; Roth JA; Glisson BS; Shames DS; Wistuba II; Wang J; Quaranta V; Minna J; Heymach JV; Byers LA
Cancer Cell; 2021 Mar; 39(3):346-360.e7. PubMed ID: 33482121
[TBL] [Abstract][Full Text] [Related]
84. [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and
Migration of Small Cell Lung Cancer with High c-Myc Expression].
Guo J; Mu D; Yu W; Sun L; Zhang J; Ren X; Han Y
Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):105-112. PubMed ID: 36872049
[TBL] [Abstract][Full Text] [Related]
85. NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.
Osborne JK; Larsen JE; Shields MD; Gonzales JX; Shames DS; Sato M; Kulkarni A; Wistuba II; Girard L; Minna JD; Cobb MH
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6524-9. PubMed ID: 23553831
[TBL] [Abstract][Full Text] [Related]
86. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.
Zhang W; Girard L; Zhang YA; Haruki T; Papari-Zareei M; Stastny V; Ghayee HK; Pacak K; Oliver TG; Minna JD; Gazdar AF
Transl Lung Cancer Res; 2018 Feb; 7(1):32-49. PubMed ID: 29535911
[TBL] [Abstract][Full Text] [Related]
87. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
88. Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.
Lissa D; Takahashi N; Desai P; Manukyan I; Schultz CW; Rajapakse V; Velez MJ; Mulford D; Roper N; Nichols S; Vilimas R; Sciuto L; Chen Y; Guha U; Rajan A; Atkinson D; El Meskini R; Weaver Ohler Z; Thomas A
Nat Commun; 2022 Apr; 13(1):2023. PubMed ID: 35440132
[TBL] [Abstract][Full Text] [Related]
89. Small cell lung cancer - news in the tumour´s biology.
Pavlíčková K; Matěj R
Cesk Patol; 2023; 59(1):18-22. PubMed ID: 37072275
[TBL] [Abstract][Full Text] [Related]
90. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
91. Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma.
Zhu Y; Li S; Wang H; Ren W; Chi K; Wu J; Mao L; Huang X; Zhuo M; Lin D
J Clin Pathol; 2023 Sep; ():. PubMed ID: 37775262
[TBL] [Abstract][Full Text] [Related]
92. Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.
Ishii J; Sato H; Yazawa T; Shishido-Hara Y; Hiramatsu C; Nakatani Y; Kamma H
Pathol Int; 2014 Sep; 64(9):415-22. PubMed ID: 25243889
[TBL] [Abstract][Full Text] [Related]
93. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities.
Desai P; Takahashi N; Kumar R; Nichols S; Malin J; Hunt A; Schultz C; Cao Y; Tillo D; Nousome D; Chauhan L; Sciuto L; Jordan K; Rajapakse V; Tandon M; Lissa D; Zhang Y; Kumar S; Pongor L; Singh A; Schroder B; Sharma AK; Chang T; Vilimas R; Pinkiert D; Graham C; Butcher D; Warner A; Sebastian R; Mahon M; Baker K; Cheng J; Berger A; Lake R; Abel M; Krishnamurthy M; Chrisafis G; Fitzgerald P; Nirula M; Goyal S; Atkinson D; Bateman NW; Abulez T; Nair G; Apolo A; Guha U; Karim B; El Meskini R; Ohler ZW; Jolly MK; Schaffer A; Ruppin E; Kleiner D; Miettinen M; Brown GT; Hewitt S; Conrads T; Thomas A
Cell Rep Med; 2024 Jun; 5(6):101610. PubMed ID: 38897168
[TBL] [Abstract][Full Text] [Related]
94. Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation.
Ito T; Kudoh S; Fujino K; Sanada M; Tenjin Y; Saito H; Nakaishi-Fukuchi Y; Kameyama H; Ichimura T; Udaka N; Kudo N; Matsuo A; Sato Y
Acta Histochem Cytochem; 2022 Jun; 55(3):75-83. PubMed ID: 35821751
[TBL] [Abstract][Full Text] [Related]
95. Insm1 controls the differentiation of pulmonary neuroendocrine cells by repressing Hes1.
Jia S; Wildner H; Birchmeier C
Dev Biol; 2015 Dec; 408(1):90-8. PubMed ID: 26453796
[TBL] [Abstract][Full Text] [Related]
96. Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.
Chen CC; Tran W; Song K; Sugimoto T; Obusan MB; Wang L; Sheu KM; Cheng D; Ta L; Varuzhanyan G; Huang A; Xu R; Zeng Y; Borujerdpur A; Bayley NA; Noguchi M; Mao Z; Morrissey C; Corey E; Nelson PS; Zhao Y; Huang J; Park JW; Witte ON; Graeber TG
Cancer Cell; 2023 Dec; 41(12):2066-2082.e9. PubMed ID: 37995683
[TBL] [Abstract][Full Text] [Related]
97. Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers.
Wooten DJ; Groves SM; Tyson DR; Liu Q; Lim JS; Albert R; Lopez CF; Sage J; Quaranta V
PLoS Comput Biol; 2019 Oct; 15(10):e1007343. PubMed ID: 31671086
[TBL] [Abstract][Full Text] [Related]
98. Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.
Voortman J; Lee JH; Killian JK; Suuriniemi M; Wang Y; Lucchi M; Smith WI; Meltzer P; Wang Y; Giaccone G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13040-5. PubMed ID: 20615970
[TBL] [Abstract][Full Text] [Related]
99. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.
Wu N; Jia D; Ibrahim AH; Bachurski CJ; Gronostajski RM; MacPherson D
Oncotarget; 2016 Sep; 7(36):57514-57524. PubMed ID: 27613844
[TBL] [Abstract][Full Text] [Related]
100. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma.
Zhu Y; Li S; Wang H; Chi K; Ren W; Huang X; Zhuo M; Lin D
Hum Pathol; 2023 Nov; 141():118-129. PubMed ID: 37586462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
